Ziopharm Oncology is focused on advancing the next generation of immunotherapies to weaponize the existing immune system with Controlled IL-12 or introduce new immune system elements with Sleeping Beauty-modified T cells to this fight against cancer. In addition to developing the next generation of immuno-oncology medicines that target multiple types of cancers, we also are targeting the cost and complexity of delivering gene and cell therapies.
Events & Presentations
Sep 17, 2020 1:20 PM EDT
Cantor Virtual Global Healthcare Conference
Sep 16, 2020 9:00 AM EDT
H.C. Wainwright 22nd Annual Global Investment Conference
Aug 6, 2020 4:30 PM EDT
Ziopharm Second Quarter 2020 Earnings Call